ABSTRACT
OriginalA
rticle
criteriaincutaneous
lymphocyticinfiltrates
DepartmentsofPathology,Dermatology,andGeneticsandBiostatistics,
SchoolofMedicalSciences,UniversidadeEstadualdeCampinas,
Campinas,SãoPaulo,Brazil
CONTEXT:Non-specificlymphocyticinfiltratesofthe skinposedifficultiesindailypracticeinpathol-ogy.Thereisstillalackofpathognomonicsigns forthedifferentialdiagnosisbetweenbenignand malignantlymphocyticinfiltrates.
OBJECTIVE:Toevaluatethemorphologicalandimmu-nohistochemicalprofileoflymphocyticinfiltrations oftheskinaccordingtoclinicaloutcome. TYPE OF STUDY: Retrospective; histopathological
andimmunohistochemicalanalysis. SETTING:Referralcenter,universityhospital. SAMPLE:28casesoflymphocyticinfiltratesofdifficult
differentialdiagnosisselectedfromtherecords. MAIN MEASUREMENTS: Eighteen histological variables and the immunophenotypic profile wereassessedusingtheCD4,CD8,CD3,CD20 andCD30lymphoidmarkersandcomparedto subsequentfollow-up.
RESULTS:Themostcommondiagnoseswere:initial mycosis fungoides (eight cases) and drug reactions (five cases). Single morphological variablesdidnotdiscriminatebetweenbenign andmalignantinfiltratesexceptforthepresence ofPautrier-Darier’smicroabscesses,whichwere found only in mycosis fungoides (p = 0.015). Patternsofsuperficialanddeepinfiltration(p= 0.037)andalsothepresenceofeosinophils(p =0.0207)weremorefrequentlyfoundinbenign lymphocytic infiltrates. Immunohistochemical profileofT-cellsubsetsshowedoverlapbetween benignandmalignantinfiltrateswithapredomi-nance of CD4-positive (helper) lymphocytes in themajorityofcases.
CONCLUSIONS: A combination of clinical and histological features remains the most reliable approach for establishing a definite diagnosis incasesoflymphoidskininfiltrates.
KEYWORDS:CutaneousT-celllymphoma.Pseudo-lymphoma. Mycosis fungoides. Immunohisto-chemistry.Differentialdiagnosis.
•LuisAlbertoMagna
•JoséVassallo
Introduction
Classictextbookshavedescribedfive“L” categories for the differential diagnosis of lymphocyticinfiltratesoftheskin:lymphoma, lymphocytoma cutis, lupus erythematosus, polymorphous light eruption, and Jessner’s lymphocyticinfiltrationoftheskin.1Leprosy, syphilis,lichenstriatus,necrobiosislipoidica, bitereactions,andthemnemonic“DRUGS” categories of dermatophytes, reticular ery- thematousmucinosis,urticarialstagesofbul-louspemphigoid,gyrateerythemas,localized scleroderma and drug reactions, have been addedtothelist.2Otherdifferentialdiagnoses includelichenoidpurpura,lichensclerosuset atrophicus,3 multiformerythemaandpsoria-sis.4Ackerman’salgorithmicmethodincludes mycosis fungoides 23 times in six different reactionpatterns.5AccordingtoDiaz-Cascajo6 thereisnosinglereliablecriterionthatallows distinction between inflammation and neo-plasiainlymphoproliferativeskindisorders.6 Distinction between benign and neoplastic skin lymphoid infiltrates is of utmost im-portanceforensuringadequatetherapyand prognosticevaluation.
Two recent publications have shown divergentopinionsregardingtheroleofthe immunophenotyping ofT-cell subsets as a diagnostic tool for cutaneous lymphocytic infiltrates.HudsonandSmoller7statedthata simpleCD4:CD8-positivelymphocyteratio canbeobtainedfromacutaneousinfiltratethat ispredominantlycomprisedofT-cellsandthat thisratiocanbeusedtomakeadiagnosisof mycosisfungoideswithahighlevelofsensitiv-ityandspecificity,onthebasisofstudiesmade
byIzbanetal.8Concomitantly,anopposing pointofview9hasbeenputforward,inwhich itisstatedthatpredominanceofCD4-positive cellsisseeninawidevarietyofnon-neoplastic conditions and therefore cannot be used to discriminatecutaneousT-celllymphomafrom inflammatorydermatoses.Theformeropinion is substantiated by some works,8,10 and the latter by others.11,12 Since no consensus has beenreachedintheliterature,thepurposeof thepresentstudywastoperformareviewof thedifferentcausesoflymphocyticinfiltrates of the skin via a retrospective study, with emphasis on morphological clues and also the role of immunophenotyping in making appropriatediagnoses.
Methods
supportedbythecourseofthedisease.For patientswithmycosisfungoidessubmitted to several biopsies, the earliest ones were selected. Only patients posing difficulties in the differential diagnosis of lymphoid infiltrateswereincluded.Obviousmalignant high-grade non-Hodgkin lymphomas were excluded.Patientssufferingfromadvanced- stageprimarynodallymphomaswithclini-cally evident involvement of the skin were excluded,aswellasthosewithevidenceof extracutaneousdiseaseappearingwithinsix months after the diagnosis, in accordance withthecriteriaoftheEuropeanOrganiza-tionforResearchandTreatmentofCancer (EORTC).14
For each biopsy specimen, slides stained withhematoxylinandeosinwereassessedfor eighteenhistologicalcriteria,inaccordancewith reactionpatternsdescribedbyAckermanand others.5,15Thesevariables,listedinTable1,were judgedtobepresentorabsentandwererecorded bytwoobserverswhohadnoclinicalinforma-tionatthetimeofevaluatingthesecriteria(Maria LetíciaCintra,AnaCristinaCotta).
Paraffin-embeddedtissuespecimenswere selectedfromfilesandsubmittedtoimmuno-histochemicalstudies.Allimmunophenotypic studies were performed on histological sec-tions of 5 µm in thickness.The antibodies used were CD4 [clone CD45RO/OPD4 (Dako-Patts, Carpentiria, USA); dilution 1:50], CD8 [clone C8/144B (Dako);
dilu-tion1:50],CD3[polyclonal(Dako);dilution 1:50], CD20 [clone L26 (Dako); dilution 1:100]andCD30[cloneBerH2(Dako);dilu-tion1:20].Asteamerwasusedastheepitope retrieval method and the Envision polymer (Dako)wasusedasthereactionamplifier.
Twoofus(JoséVassallo,AnaCristinaCotta) evaluatedtheimmunohistochemicalsectionsfor thepercentageofstainedcells,withoutknowl-edgeofthepreviousdiagnosis.
Datawereanalyzedviathechi-squaredand Kruskal-Wallistestsrespectivelyformorphologi- calandimmunohistochemicalvariables.Statisti-calsignificancewassetatp<0.05.
Results
Patientsweregroupedaccordingtoclinical dataandfollow-up.Thegroupsconsistedof: mycosisfungoides(8cases),benignlymphoid infiltrates (12 cases) and suspected mycosis fungoides(8cases).Thelattercategoryincluded patientsunderprolongedfollow-uppresenting large-plaqueparapsoriasis(4cases),orincom- pleteclinicalandhistologicalfindingsformy-cosisfungoidesandalsoincompleteresponseto non-destructivetherapies(4cases).11
The inflammatory dermatoses found wereskinallergiesduetodrugs(5cases,one with prominent photosensitivity), pseudo- lymphoma(2cases,oneassociatedwithanti- hypertensivedrugs),Jessner’slymphocyticin-filtration,neurodermatitis,prurigonodularis,
lupuserythematosus,anderythemaannulare centrifugum(1caseeach).
Fromtheeighteenmorphologicalcrite-riastudied,Pautrier-Darier’smicroabscesses were present only in some of the mycosis fungoidespatients(3outof8cases;37.5%) (Figure1).Superficialanddeeplymphocytic infiltrateswerelesscommonamongmycosis fungoidespatientsandmoreprominentin benign infiltrates (p = 0.037).The most frequent epidermal reaction pattern was psoriasiformhyperplasia,whichwaspresent inabouthalfofcases.Therewascompact hyperkeratosis,orparakeratosis,in75%of themycosisfungoidescases,butthisfind-ing was also common in the groups with inflammatory dermatosis and suspected lymphoma.Absenceofspongiosiswasnot aprominentfeatureinmycosisfungoides, incomparisonwiththeothergroups.Su-perficial perivascular patterns combined with interstitial patterns of infiltration were present in the majority of patients in all groups and band-like subepidermal infiltrationwaspresentinmorethanhalfof themycosisfungoidespatients.Prominent exocytosiswithscantspongiosiswasmore frequent in the lymphoma and suspected lymphoma(62.5%and50.0%)casesthan inthebenigninfiltratecases(30.8%).The presenceofeosinophilswasmorecommon in the group of benign lymphocytic infil-trates(p=0.0207)(Table1).
Table1.Morphologicalfindingsfromcutaneousinfiltratesoftheskinin28casesofcutaneouslymphoidinfiltrates
Morphologiccriteria Diagnosis
Mycosisfungoides n/total%
Benigndermatosis n/total%
Parapsoriasis
n/total% pvalue Band-likeinfiltration 5/8 62.5 4/12 33.3 2/8 25.0 0.2631 Psoriasiformhyperplasia 4/8 50.0 8/12 67.7 4/8 50.0 0.6778
Spongiosis 2/8 25.0 0/12 0 1/8 12.5 0.2046
Abnormalcornifiedlayer 6/8 75.0 10/12 83.3 4/8 50.0 0.2614 Superficialperivascular 7/8 87.5 11/12 91.7 8/8 100 0.6104 Interstitialinfiltration 8/8 100 12/12 100 7/8 87.5 0.2735 Superficialanddeepinfiltration 0/8 0 7/12 63.6 4/8 50.0 0.0377 Folliculitisandperifolliculitis 2/8 28.6 7/12 63.6 3/8 37.5 0.2916 Nodularinfiltration 1/8 14.3 2/12 16.7 1/8 12.5 0.9665 Disproportionateexocytosis 5/8 62.5 4/12 33.3 4/8 50.0 0.4276 Prominenteosinophils 2/8 25.0 7/12 58.3 0/8 0 0.0207 Alignedlymphocytes 5/8 62.5 7/12 58.3 5/8 62.5 0.9753 Lymphocytehalos 5/8 62.5 6/12 50.0 4/8 50.0 0.8357 Pautrier-Darier’smicroabscesses 3/8 37.5 0/12 0 0/8 0 0.0150 Atypicallymphocytes 6/8 62.5 7/12 58.3 2/8 25.0 0.2425 Largerintraepidermal 1/8 12.5 3/12 25.0 0/8 0 0.2895
Fibrosis 1/8 12.5 4/12 33.3 3/8 37.5 0.4823
Theimmunohistochemicalstudiesdem-onstratedthepresenceofapredominantT-cell immunophenotype in all the cases selected, withlessthan30%B-cellsinallcases,except for one patient with suspected cutaneous lymphoma.16CD30wasnegativeexceptfor twomycosisfungoidescases.
There was prominent helper/inducer T-cell(CD4-positive)predominance(Figure 2),incomparisonwithsuppressor/cytotoxic (CD8-positive) stained cells, for all groups. The CD4:CD8 ratio was about 4. CD4 lymphocytes constituted about 80% of the infiltrating lymphocytes in all groups. Statistical analysis did not show significant differencesbetweenthegroupsinrelationto theCD4/CD8ratio.Therewasonemycosis fungoides case with predominance of CD8 lymphocytes(Figure3andTable2).
Discussion
Thereisalargegroupofskindiseases that are characterized by increased num-bers of lymphocytic cells. For therapeutic purposes, benign hyperplasia needs to be distinguished from neoplastic conditions. Inourmaterial,themostdifficultdifferen-tial diagnosis was between drug reactions andcutaneousT-celllymphomas.Bothare morefrequentinolderpatientsundergoing chronictreatments,especiallywithanti-hy-pertensivedrugs,andtheyarealsodescribed intheetiologyofsomepseudolymphomas.11 Another important aspect that must be consideredinrelationtodrugreactionsis theirclinicalpresentationaserythroderma simulatingSézarySyndrome.Thedifferen-tialdiagnosisforexfoliativeerythrodermais alwaysdifficultandmaynotbeestablished in about 30% to 40% of such patients.17 This includes atopic dermatitis, psoriasis, pityriasisrubrapilaris,contactdermatitis, seborrheicdermatitis,pemphigusfoliaceous, leukemiaandotherinternalmalignancies.17 Infact,itmaybenecessarytotakeseveral biopsiesinordertodetectdefinitesignsof cutaneous lymphoma. Lupus erythemato-sus and leprosy cases are frequent in our dailyroutine,butonlyonecasepresented histological findings allowing differential diagnosiswithmycosisfungoides.
Among the morphological variables that were evaluated, Pautrier-Darier’s mi-croabscesses were present only in mycosis fungoidescasesandwereabsentintheother groups. Although 100% specific for this groupofpatients,Pautrier-Darier’smicro-abscesseswerepresentonlyin37.5%ofour
Figure1.Mycosisfungoides:compactorthokeratosis, Pautrier-Darier’smicroabscess,moderatespongiosis(hema-toxylin-eosin;200x).
Figure2. Benignlymphocyticinfiltrationoftheskin:CD4-positivelymphoidcells(immunoperoxidase;200x).
mycosisfungoidescases.Thehighspecific-ityandlowsensitivityofPautrier-Darier’s microabscesses for mycosis fungoides that we found is in agreement with previous studiesreportingfrequenciesfrom4.2%to 37.5%.4,15,18,19Prominenteosinophilswere morefrequentwithinbenignlymphoidin-filtrates.Thismayreflectthepredominance of drug reaction cases in this group.The patternofsuperficialanddeepperivascular infiltrationwasmorecommonlyseeninbe-nignlymphocyticinfiltrationsandsuspected lymphomacases.
The mycosis fungoides patients had beensubmittedtoseveralbiopsies.Disease progression is related to deeper infiltrates butwestudiedjusttheinitialbiopsyspeci-mens.Prominentatypicallymphocytesdid not discriminate for mycosis fungoides. Cerebriformlymphocytesareusuallycon-sideredtobediscriminatingvariables4for thediagnosisofmycosisfungoides,butthey werenotprominentinthesectionswestud-ied.Thiswasperhapsbecauseweusedthe earlymycosisfungoidesbiopsiesinthecases whenmultiplebiopsieshadbeenperformed. Thelowpercentageofspongiosiswithinthe benigninfiltrategroupmaybeexplainedby thechronicnatureoftheselectedcasesin thissample.Superficial,deepandnodular infiltrateandfolliculitiscouldnotbeevalu-atedintwocasesofmycosisfungoidesand oneofbenignlymphoidinfiltrationdueto scantreticulardermis,andtheabsenceof adnexainonecase.
Onemycosisfungoidescasehadlym-phocytes that were 50% CD30-positive, but this did not change the diagnosis to CD30-positive large T-cell lymphoma. CD30shouldbeexpressedbythemajority (>75%)ofneoplasticcells,inaconsistent morphological context, to be included in this group.14,20 The absence of CD30 positivity in the other two groups does not characterize CD30 as a marker for malignancy, as it may be encountered in non-malignant lymphoproliferative dis-orders6,20,21 and even in association with non-lymphoproliferativeentities.22
Two studies published in 1999 took opposingpointsofviewconcerningtherole of the immunophenotyping of cutaneous infiltrates.7,9 AhighCD4:CD8ratiowasre-gardedasbothsensitiveandspecificforthe diagnosisofmycosisfungoidesbyHudson and Smoller,7 on basis of an earlier study byIzbanetal.8Inthatstudy,835biopsies from 29 mycosis fungoides patients were evaluated.They found a CD4:CD8 ratio
ofmorethan2:1in31ofthe35sections, butnocontrolgroupresultswerereported in that study. Bakels et al.23 performed a semiquantitative estimation of CD8-posi-tivecellsinfrozensections.Theyfounda greater admixture of CD8-positive small lymphocytesin11pseudolymphomacases thanin9mycosisfungoidescases.Nosta-tisticallysignificantdifferencebetweenthe groupswasdescribed.23
Table2.Immunohistochemicalstudiesof28casesofcutaneouslymphoidinfiltrates
Mycosisfungoides CD4(%) CD8(%) CD3(%) CD30(%) CD20(%)
Median 80 20 85 0 10
Mean 72.2 24.4 82.5 7.5 11.2
SD 23.9 25 12.8 17.5 9.9
Min 30 1 60 0 0
Max 100 80 100 50 30
Benigndermatosis
Median 80 20 90 0 10
Mean 75.4 23.9 73.1 0 10
SD 24.5 25.6 30.9 0 9.1
Min 30 1 10 0 0
Max 100 80 100 0 30
Parapsoriasis
Median 80 30 90 0 5
Mean 76.3 37.5 73.8 0 13.8
SD 18.5 24.9 23.3 0 27.2
Min 40 10 40 0 0
Max 100 80 90 0 80
pvalue 0.9910 0.2403 0.8563 - 0.6412
SD=standarddeviation;Min=minimum,Max=maximum.
wereinthedermis.Thisincludedabout9.6 CD4cellsand5.3CD8cellsintheepidermis versus250.2CD4cellsand124.8CD8cells inthedermis.Therefore,weshouldconsider thatthisfindingismuchmorerelatedtothe subsetoflymphocytesthatcontributetothe phenomenon of epidermotropism than to the CD4:CD8 ratio itself.The reason why the mean observed was so high was mostly becauseoftwomycosisfungoidescaseswith prominentepidermotropism.Anestimateof theproportionofintraepidermallymphocytes wasmadeforthecasesinthepresentstudy,but thenumberofcellsdetectedwastoosmallto allowadequatestatisticalanalysisanddidnot differfromtheCD4-CD8subtypeofT-cells identifiedinthecorrespondingdermis(data notpublished).
Ontheotherhand,Glusacetal.9believed thatpredominanceofCD4positivecellsis
seeninawidevarietyofnon-neoplasticcon- ditionsandcannotbeusedasadiscrimina-toryparameterforthedifferentialdiagnosis between cutaneousT-cell lymphomas and inflammatorydermatoses.Someauthorsalso regardtheCD4:CD8ratioasanonspecific finding,giventheexistenceofcasesofmyco-sisfungoideswithpredominantCD8.
CONCLUSIONS
Ourresultscorroboratepreviousdatain which it was concluded that the immuno-phenotypicprofilemustbeconsideredwith caution because benign lymphocytic infil-trates9,11aswellassmallplaqueparapsoriasis biopsyspecimens12maydisplaypredominant CD4 expression. Definite diagnosis still needs clinicopathological correlation and carefulfollow-up.
1. ElderD,ElenitsasR,JawarskyC,JohnsonB.Lever’sHistopathology oftheSkin.8thedition.Philadelphia:Lippincott-Raven;1997.
2. WeedonD.SkinPathology.London:ChurchillLivingstone;1997. 3. MingM,LeBoitPE.Candermatopathologistsreliablymakethe
diagnosisofmycosisfungoides?Ifnot,whocan?ArchDermatol. 2000;136(4):543-6.
4. SantucciM,BiggeriA,FellerAC,MassiD,BurgG.Efficacy of histologic criteria for diagnosing early mycosis fungoides: anEORTCcutaneouslymphomastudygroupinvestigation. EuropeanOrganizationforResearchandTreatmentofCancer. AmJSurgPathol.2000;24(1):40-50.
5. Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases.2ndedition.Baltimore:Williams&Wilkins;1997.
6. Diaz-CascajoC.Strongimmunoexpressionofthemonoclonal antibodyCD-30inlymphocyticinfiltratesoftheskinnotby itself evidence for diagnosing malignant lymphoma. Am J Dermatopathol.2001;23(1):79-80.
7. HudsonAR,SmollerBR.Immunohistochemistryindiagnostic dermatopathology.DermatolClin.1999;17(3):667-89. 8. IzbanKF,HsiED,AlkanS.Immunohistochemicalanalysisof
mycosisfungoidesonparaffin-embeddedtissuesections.Mod Pathol.1998;11(10):978-82.
9. Glusac EJ, Shapiro PE, McNiff JM. CutaneousT-cell lym-phoma.Refinementintheapplicationofcontroversialhistologic criteria.DermatolClin.1999;17(3):601-14.
10. NuckolsJD,SheaCR,HorensteinMG,BurchetteJL,Prieto VG.QuantitationofintraepidermalT-cellsubsetsinformalin-fixed,paraffin-embeddedtissuehelpsinthediagnosisofmycosis fungoides.JCutanPathol.1999;26(4):169-75.
11. RijlaarsdamJU,SchefferE,MeijerCJ,WillemzeR.Cutane-ouspseudo-T-celllymphomas.Aclinicopathologicstudyof20 patients.Cancer.1992;69(3):717-24.
12. HaeffnerAC,SmollerBR,ZepterK,WoodGS.Differentiation andclonalityoflesionallymphocytesinsmallplaqueparapso-riasis.ArchDermatol.1995;131(3):321-4.
13. LeBoitPE.Variantsofmycosisfungoidesandrelatedcutaneous T-celllymphomas.SeminDiagnPathol.1991;8(2):73-81. 14. WillemzeR,KerlH,SterryW,etal.EORTCclassificationfor
primarycutaneouslymphomas:aproposalfromtheCutaneous LymphomaStudyGroupoftheEuropeanOrganizationforRe-searchandTreatmentofCancer.Blood.1997;90(1):354-71. 15. SmollerBR,BishopK,GlusacE,KimYH,HendricksonM.
Reassessmentofhistologicparametersinthediagnosisofmycosis fungoides.AmJSurgPathol.1995;19(12):1423-30. 16. YoshinoT,MukuzonoH,AokiH,etal.Anovelmonoclonal
antibody(OPD4)recognizingahelper/inducerTcellsubset. Its application to paraffin-embedded tissues. Am J Pathol. 1989;134(6):1339-46.
17. SamsWM,LynchPJ.PrinciplesandPracticeofDermatology. 2ndedition.Singapore:ChurchillLivingstone;1996.
18. NickoloffBJ.Light-microscopicassessmentof100patientswith patch/plaque-stagemycosisfungoides.AmJDermatopathol. 1988;10(6):469-77.
19. ShapiroPE,PintoFJ.Thehistologicspectrumofmycosisfungoi-des/Sézarysyndrome(cutaneousT-celllymphoma).Areviewof 222biopsies,includingnewlydescribedpatternsandtheearliest pathologicchanges.AmJSurgPathol.1994;18(7):645-67. 20.BeljaardsRC,KaudewitzP,BertiE,etal.Primarycutaneous
CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer. 1993;71(6):2097-104.
21. Segal GH, Kjeldsberg CR, Smith GP, Perkins SL. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases. Am J Clin Pathol. 1994;102(3):292-8.
22. CespedesYP,RockleyPF,FloresF,RuizP,KaiserMR,Elgart GW. Is there a special relationship between CD30-positive lymphoproliferative disorders and epidermal proliferation? J CutanPathol.2000;27(6):271-5.
23. BakelsV,vanOostveenJW,vanderPutteSC,MeijerCJ,Wil-lemzeR.Immunophenotypingandgenerearrangementanalysis provideadditionalcriteriatodifferentiatebetweencutaneous T-celllymphomasandpseudo-T-celllymphomas.AmJPathol. 1997;150(6):1941-9.
References
Avaliaçãodoscritériosdiagnósticosnasinfiltra-çõeslinfocitáriascutâneas
CONTEXTO: Infiltraçõeslinfocitáriasnão-espe- cíficasdapelerepresentamdificuldadesdiag-nósticasnapráticadiáriadapatologia.Não hásinaispatognomônicosparaodiagnóstico diferencial entre infiltrações linfocitárias benignasemalignas.
OBJETIVOS: Avaliar o perfil morfológico e imunofenotípicodasinfiltraçõeslinfocitárias deacordocomaevoluçãoclínica.
TIPO DE ESTUDO: Retrospectivo: análise histopatológicaeimunoistoquímica.
LOCAL:Centrodereferência,hospitaluniver-sitário.
AMOSTRA:28casosdeinfiltraçõeslinfocitárias dediagnósticodiferencialdifícilselecionados dosarquivos.
PRINCIPAISMEDIDAS:Análisede18variáveis histológicaseperfilimunofenotípicoutilizando osmarcadoreslinfóidesCD4,CD8,CD3,CD20 eCD30,comparadosàevoluçãoclínica.
RESULTADOS: Os diagnósticos mais comuns foram:micosefungóide—inicial(oitocasos) e farmacodermias (cinco casos). Variáveis morfológicas isoladas não discriminaram infiltradosbenignosemalignos,excetopela presença dos microabscessos de Pautrier-Darier, que foram encontrados apenas na micosefungóide(p=0,015).Opadrãode infiltraçãosuperficialeprofunda(p=0,037) eapresençadeeosinófilos(p=0,0207)foram maisfreqüentesnasinfiltraçõeslinfocitárias benignas. O perfil imunoistoquímico dos linfócitosTmostrousobreposiçãoentreinfil-traçõesbenignasemalignas,compredomínio delinfócitosTauxiliaresCD4positivosna maioriadoscasos.
CONCLUSÃO:Acombinaçãodasinformações clínicasehistológicasrepresentaaabordagem maisconsistenteparaodiagnósticodiferen-cialdosinfiltradoslinfóidescutâneos.
PALAVRAS-CHAVE: Linfoma de CélulasT Cutâneo. Pseudolinfoma. Micose fungóide. Imunohistoquímica.Diagnósticodiferencial.
PUBLISHINGINFORMATION
AnaCristinaCotta,MD.Pathologist.SchoolofMedical Sciences,UniversidadeEstadualdeCampinas,Campinas, SãoPaulo,Brazil.
MariaLetíciaCintra,MD,PhD.ProfessorofPathology and Chief of the Dermatopathology Section, School of MedicalSciences,UniversidadeEstadualdeCampinas, Campinas,SãoPaulo,Brazil.
ElemirMacedodeSouza,MD,PhD.ProfessorofDerma-tology,SchoolofMedicalSciences,UniversidadeEstadual deCampinas,Campinas,SãoPaulo,Brazil.
LuisAlbertoMagna,MD,PhD.ProfessorofGenetics andBiostatistics,SchoolofMedicalSciences,Universidade EstadualdeCampinas,Campinas,SãoPaulo,Brazil. José Vassallo, MD, PhD. Professor of Pathology and
chiefoftheHematopathologySection,SchoolofMedical Sciences,UniversidadeEstadualdeCampinas,Campinas, SãoPaulo,Brazil.
Sources of funding: Grants from Fundo de Apoio ao EnsinoePesquisa(FAEP),Unicamp,nos.1074/00and 1219/01.
Conflictofinterest:Notdeclared
Dateoffirstsubmission:September18,2003 Lastreceived:October30,2003 Accepted:November13,2003
Addressforcorrespondence: JoséVassallo
FaculdadedeCiênciasMédicasdaUniversidade EstadualdeCampinas
DepartamentodeAnatomiaPatológica CaixaPostal6111
Campinas(SP)—Brasil—CEP13083-970 Tel./Fax(+5519)3289-3897 E-mail:posanat@fcm.unicamp.br
COPYRIGHT©2004,AssociaçãoPaulistadeMedicina